Abstract
Formation of a virus particle protects the viral genome from exogenous agents and permits release of its content upon delivery to the target cell. Retroviruses generally cause persistent infections and do not usually lyse their host cells. In this case virus morphogenesis requires transport of individual virion components to a specific site within the producer cell, with subsequent assembly and release by budding from the plasma membrane. Extracellular infectious retroviruses are composed of an inner core containing the RNA genome and the viral replication enzymes (products of the pol gene) enclosed in a host-derived lipid membrane that contains the viral glycoproteins (products of the env gene; Fig. 1). Morphogenesis of any retrovirus therefore requires the morphoieic function of
the core proteins encoded by the gag gene at the 5′ end of the genome. Incorporation of the othe components (Pol and Enc proteins and genomic RNA) is not necessary for particle formation, but is necessary for infectivity and may also be important in targeting and assembly. Additional viral and cellular proteins have been identified in infectious retrovirus preparations, most notably in the case of human immunodeficiency virus type 1 (HIV-1). Some of these accesory proteins serve important functions (see Chap. 7) while others are fortuitous contaminants, due to the fact that retroviruses cannot be purified to homogeneity. Moreover, particle assembly in the infected cell can lead to nonspecific incorporation of cytoplasmic proteins or nucleic acids if these are available at the assembly site and are not actively excluded.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aboud M, Shoor R, Bari S, Hasan Y, Shurtz R, Malik Z, Salzberg S (1982) Biochemical analysis and electron microscopic study on intracellular virions in NIH/3T3 mouse cells chronically infected with Moloney murine leukemia virus: effect of interferon. J Gen Virol 62: 219–225
Aloia RC, Jensen FC, Curtain CC, Mobley PW, Gordon LM (1988) Lipid composition and fluidity of the human immunodeficiency virus. Proc Natl Acad Sei USA 85: 900–904
Aloia RC, Tian H, Jensen FC (1993) Lipid composition and fluidity of the human immunodeficiency virus envelope and host cell plasma membranes. Proc Natl Acad Sei USA 90: 5181–5185
Arthur LO, Bess JW Jr, Sowder RC II, Benveniste RE, Mann DL, Chermann JC, Henderson LE (1992) Cellular proteins bound to immunodeficiency viruses: implications for pathogenesis and vaccines. Science 258: 1935–1938
Bathurst IC, Chester N, Gibson HL, Dennis AF, Steimer KS, Barr PJ (1989) N myristylation of the human immunodeficiency virus type 1 gag polyprotein precursor in Saccharomyces cerevisiae. J Virol 63: 3176–3179
Bennett RP, Nelle TD, Wills JW (1993) Functional chimeras of the Rous sarcoma virus and human immunodeficiency virus gag proteins. J Virol 67: 6487–6498
Biswas P, Poli G, Kinter AL, Justement JS, Stanley SK, Maury WJ, Bressler P, Orenstein JM, Fauci AS (1992) Interferon gamma induces the expression of human immunodeficiency virus in persistently infected promonocytic cells (U1) and redirects the production of virions of intracytoplasmic vacuoles in phorbol myristate acetate differentiated U1 cells. J Exp Med 176: 739–750
Blenis J, Resh MD (1993) Subcellular localization specified by protein acylation and phosphorylation. Curr Opin Cell Biol 5: 984–989
Bolognesi DP, Montelaro RC, Frank H, Schafer W (1978) Assembly of type C oncornaviruses: a model. Science 199: 183–186
Bour S, Schubert U, Peden K, Strebel K (1996) The envelope glycoprotein of human immunodeficiency virus type 2 has a Vpu-like activity that enhances viral particle release. J Virol 70: 820–829
Bourinbaiar AS, Phillips DM (1991) Transmission of human immunodeficiency virus from monocytes to epithelia. J Acquir Immune Defic Syndr 4: 56–63
Bowerman B, Brown PO, Bishop JM, Varmus HE (1989) A nucleoprotein complex mediates the integration of retroviral DNA. Genes Dev 3: 469–478
Bray M, Prasad S, Dubay WJ, Hunter E, Jeang K-T, Rekosh D, Hammarskjòld M-L (1994) A small element from the Mason-Pfizer monkey virus genome makes human immunodeficiency virus type 1 expression and replication Rev-independent. J Virol 91: 1256–1260
Brody BA, Rhee SS, Sommerfelt MA, Hunter E (1992) A viral protease mediated cleavage of the transmembrane glycoprotein of Mason Pfizer monkey virus can be suppressed by mutations within the matrix protein. Proc Natl Acad Sci USA 89: 3443–3447
Brody BA, Rhee SS, Hunter E (1994) Postassembly cleavage of a retroviral glycoprotein cytoplasmic domain removes a necessary incorporation signal and activates fusion activity. J Virol 68: 4620–4627
Bryant M, Ratner L (1990) Myristoylation dependent replication and assembly of human immunodeficiency virus 1. Proc Natl Acad Sci USA 87: 523–527
Bugelski PJ, Maleeff BE, Klinkner AM, Ventre J, Hart TK (1995) Ultrastructural evidence of an interaction between Env and Gag proteins during assembly of HIV type 1. AIDS Res Hum Retroviruses 11: 55–64
Bukrinsky Ml, Sharova N, Dempsey MP, Stanwick TL, Bukrinskaya AG, Haggerty S, Stevenson M (1992) Active nuclear import of human immunodeficiency virus type 1 preintegration complexes. Proc Natl Acad Sci USA 89: 6580–6584
Bukrinsky Ml, Haggerty S, Dempsey MP, Sharova N, Adzhubel A, Spitz L, Lewis P, Goldfarb D, Emerman M, Stevenson M (1993a) A nuclear localization signal within HIV 1 matrix protein that governs infection of non dividing cells. Nature 365: 666–669
Bukrinsky Ml, Sharova N, McDonald TL, Pushkarskaya T, Tarpley WG, Stevenson M (1993b) Association of integrase, matrix, and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection. Proc Natl Acad Sci USA 90: 6125–6129
Burnette B, Yu G, Felsted RL (1993) Phosphorylation of HIV 1 gag proteins by protein kinase C J Biol Chem 268: 8698–8703
Burstein H, Bizub D, Skalka AM (1991) Assembly and processing of avian retroviral gag polyproteins containing linked protease dinners. J Virol 65: 6165–6172
Campbell S, Vogt VM (1995) Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol 69: 6487–6497
Canivet M, Jouanny C, Fourcade A, Lasneret J, Rhodes-Feuillette A, Peries J (1983) Effect of human interferon on type D retroviruses multiplication in chronically infected cell lines. J Interferon Res 3: 53–64
Chatterjee S, Bradac JA, Hunter E (1982) Effect of monensin or Mason Pfizer monkey virus glycoprotein synthesis. J Virol 44: 1003–1012
Chazal N, Carrière C, Gay B, Boulanger P (1994) Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirusinfected cells. J Virol 68: 111–122
Chazal N, Gay B, Carrière C, Tournier J, Boulanger P (1995) Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. J Virol 69: 365–375
Damsky CH, Sheffield JB, Tuszynski GP, Warren L (1977) Is there a role for actin in virus budding? J Cell Biol 75: 593–605
Delchambre M, Gheysen D, Thines D, Thiriart C, Jacobs E, Verdin E, Horth M, Burny A, Bex F (1989) The Gag precursor of simian immunodeficiency virus assembles into virus-like particles. EMBO J 8: 2653–2660
Deminie CA, Emerman M (1994) Functional exchange of an oncoretrovirus and a lentivirus matrix protein. J Virol 68: 4442–4449
Dorfman T, Mammano F, Haseltine WA, Göttlinger HG (1994) Role of the matrix protein in the virion association of the human immunodeficiency virus type 1 envelope glycoprotein. J Virol 68: 1689–1696
Edbauer CA, Naso RB (1983) Cytoskeleton associated Pr65gag and retrovirus assembly. Virology 130: 415–426
Edbauer CA, Naso RB (1984) Cytoskeleton associated Pr65gag and assembly of retrovirus temperature sensitive mutants in chronically infected cells. Virology 134: 389–397
Evans SS, Wang WC, Gregorio CC, Han T, Repasky EA (1993) Interferon-a alters spectrin organization in normal and leukemic human B lymphocytes. Blood 81: 759–766
Fäcke M, Janetzko A, Shoeman RL, Kräusslich HG (1993) A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol 67: 4972–4980
Fernie BF, Poli G, Fauci AS (1991) Alpha interferon suppresses virion but not soluble human immunodeficiency virus antigen production in chronically infected T lymphocytic cells. J Virol 65: 3968–3971
Fischer U, Huber J, Boelens WC, Mattaj IW, Lührmann R (1995) The HIV-1 Rev activation domain is a nuclear export signal that accesses an export pathway used by specific cellular RNAs. Cell 82: 475–483
Franke EK, Yuan HEH, Luban J (1994) Specific incorporation of cyclophilin A into HIV-1 virions. Nature 372: 4972 - 4980
Freed EO, Martin MA (1994) HIV-1 infection of non-dividing cells. Nature 369: 107–108
Freed EO, Martin MA (1995) Virion incorporation of envelope glycoproteins with long but not short cytoplasmic tails is blocked by specific single amino acid substitutions in the human immunodeficiency virus type 1 matrix. J Virol 69: 1984–1989
Freed EO, Orenstein JM, Buckler White AJ, Martin MA (1994) Single amino acid changes in the human immunodeficiency virus type 1 matrix protein block virus particle production. J Virol 68: 5311–5320
Freed EO, Englund G, Martin MA (1995) Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection. J Virol 69: 3949–3954
Gallay P, Swingler S, Aiken C, Trono D (1995a) HIV-1 infection of nondividing cells: C-terminal phosphorylation of the viral matrix protein is a key regulator. Cell 80: 379–388
Gallay P, Swingler S, Song J, Bushman F, Trono D (1995b) HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase. Cell 83: 569–576
Gallina A, Mantoan G, Rindi G, Milanesi G (1994) Influence of MA internal sequences, but not of the myristylated N-terminus sequence, on the binding site of HIV-1 Gag protein. Biochem. Biophys Res Commun 204: 1031–1038
Garoff H, Wilschut J, Liljeström P, Wahlberg JM, Bron R, Suomalainen M, Smyth J, Salminen A, Barth BU, Zhao H et al (1994) Assembly and entry mechanisms of Semliki Forest virus. Arch Virol [Suppl] 9: 329–338
Gebhardt A, Bosch JV, Ziemiecki A, Friis RR (1984) Rous sarcoma virus p19 and gp35 can be chemically crosslinked to high molecular weight complexes: an insight into virus assembly. J Mol Biol 174: 297–317
Gelderblom HR, Hausmann EH, Özel M, Pauli G, Koch MA (1987) Fine structure of human immunodeficiency virus ( HIV) and immunolocalization of structural proteins. Virology 156: 171–176
Gendelman HE, Baca L, Turpin JA, Kalter DC, Hansen BD, Orenstein JM, Friedman RM, Meitzer MS (1990) Restriction of HIV replication in infected T cells and monocytes by interferon alpha. AIDS Res Hum Retroviruses 6: 1045–1049
Gheysen D, Jacobs E, de Foresta F, Thiriart C, Francotte M, Thines D, De Wilde M (1989) Assembly and release of HIV 1 precursor Pr55gag virus like particles from recombinant baculovirus infected insect cells. Cell 59: 103–112
Goepfert PA, Wang G, Mulligan MJ (1995) Identification of an ER retrieval signal in a retroviral glycoprotein. Cell 82: 543–544.
González SA, Affranchino JL, Gelderblom HR, Burny A (1993) Assembly of the matrix protein of simian immunodeficiency virus into virus like particles. Virology 194: 548–556
Göttlinger HG, Sodroski JG, Haseltine WA (1989) Role of capsid precursor processing and myristoylation in morphogenesis and infectivity of human immunodeficiency virus type 1. Proc Natl Acad Sei USA 86: 5781–5785
Göttlinger HG, Dorfman, T, Cohen EA, Haseltine WA (1993) Vpu protein of human immunodeficiency virus type 1 enhances the release of capsids produced by gag gene constructs of widely divergent retroviruses. Proc Natl Acad Sei USA 90: 7381–7385
Granowitz C, Goff SP (1994) Substitution mutations affecting a small region of the moloney murine leukemia virus MA Gag protein block assembly and release of virion particles. Virology 205: 336–344
Grief C, Farrar GH, Kent KA, Berger EG (1991) The assembly of HIV within the Golgi apparatus and Golgi derived vesicles of JM cell syncytia. AIDS 5: 1433–1439
Hansen M, Jelinek L, Whithing S, Barklis E (1990) Transport and assembly of Gag proteins into Moloney murine leukemia virus. J Virol 64: 5306–5316
Hansen M, Jelinek L, Jones RS, Stegeman Olsen J, Barklis E (1993) Assembly and composition of intracellular particles formed by Moloney murine leukemia virus J Virol 67: 5163–5174
Hayakawa T, Miyazaki T, Misumi Y, Kobayashi M, Fujisawa Y (1992) Myristoylation-dependent membrane targeting and release of the HTLV-I Gag precursor, Pr53gag, in yeast. Gene 119: 273–277
Heine UL, Demsey AE, Tucker RW, Bykovsky AF (1985) Intracellular type A retrovirus movement associated with an intact microtubule system. J Gen Virol 66: 275–282
Heinzinger NK, Bukrinsky Ml, Haggerty SA, Ragland AM, Kewalramani V, Lee MA, Gendelman HE, Ratner L, Stevenson M, Emerman M (1994) The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells. Proc Natl Acad Sei USA 91: 7311–7315
Henderson LE, Krutzsch HC, Oroszlan (1983) Myristyl amino-terminal acylation of murine retrovirus proteins: an unusual post-translational protein modification. Proc Natl Acad Sei USA 80: 339–343
Hill CP, Worthy lake D, Bancroft DP, Christensen AM, Sundquist Wl (1996) Crystal structures of the trimeric HIV-1 matrix protein: implications for membrane association and assembly. Proc Natl Acad Sei USA 93 (in press)
Höner B, Shoeman RL, Traub P (1991) Human immunodeficiency virus type 1 protease microinjected into cultured human skin fibroblasts cleaves vimentin and affects cytoskeletal and nuclear architecture. J Cell Sei 100: 799–807
Hoshikawa N, Kojima A, Yasuda A, Takayashiki E, Masuko S, Chiba J, Sata T, Kurata T (1991) Role of the gag and pol genes of human immunodeficiency virus in the morphogenesis and maturation of retrovirus like particles expressed by recombinant vaccinia virus: an ultrastructural study. J Gen Virol 72: 2509–2517
Jacobs E, Gheysen D, Thines D, Francotte M, de Wilde M (1989) The HIV 1 Gag precursor Pr55gag synthesized in yeast is myristoylated and targeted to the plasma membrane. Gene 79: 71–81
Jones TA, Blaug G, Hansen M, Barklis E (1990) Assembly of gag ß-galactosidase proteins into retrovirus particles. J Virol 64: 2265–2279
Johnston DS (1995) The intracellular localization of messenger RNAs. Cell 81: 161–170
Jorgensen EC, Pedersen FS, Jorgensen P (1992) Matrix protein of Akv murine leukemia virus: genetic mapping of regions essential for particle formation. J Virol 66: 4479–4487
Kaplan AH, Swanstrom R (1991) Human immunodeficiency virus type 1 Gag proteins are processed in two cellular compartments. Proc Natl Acad Sei USA 88: 4528–4532
Kaplan AH, Zack JA, Knigge M, Paul DA, Kempf DJ, Norbeck DW, Swanstrom R (1993) Partial inhibition of the human immunodeficiency virus type 1 protease results in aberrant virus assembly and the formation of noninfectious particles J Virol 67: 4050–4055
Kaplan AH, Manchester M, Swanstrom R (1994) The activity of the protease of human immunodeficiency virus type 1 is initiated at the membrane of infected cells before the release of viral proteins and is required for release of occur with maximum efficiency. J Virol 68: 6782–6786
Karacostas V, Wolffe EJ, Nagashima K, Gonda MA, Moss B (1993) Overexpression of the HIV 1 gag pol polyprotein results in intracellular activation of HIV 1 protease and inhibition of assembly and budding of virus like particles. Virology 193: 661–671
Kim J, Mosior M, Chung LA, Wu H, McLaughlin S (1991) Binding of peptides with basic residues to membranes containing acidic phospholipids. Biophys J 60: 135–148
Klikova M, Rhee SS, Hunter E, Ruml T (1995) Efficient in vivo assembly of retroviral capsids from gag precursor expressed in bacteria J Virol 69: 1093–1098
Klimkait T, Strebel K, Hoggan MD, Martin MA, Orenstein JM (1990) The human immunodeficiency virus type 1 specific protein vpu is required for efficient virus maturation and release J Virol 64: 621–629
Konvalinka J, Litterst MA, Welker R, Kottier H, Rippmann F, Heuser AM, Kräusslich HG (1995a) An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity J Virol 69: 7180–7186
Konvalinka J, Löchelt M, Zentgraf H, Flügel RM, Kräusslich HG (1995b) Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol 69: 7264–7268
Kräusslich HG (1991) Human immunodeficiency virus proteinase dimer as component of the viral polyprotein prevents particle assembly and viral infectivity. Proc Natl Acad Sei USA 88: 3213–3217
Kräusslich HG (1992) Specific inhibitor of human immunodeficiency virus proteinase prevents the cytotoxic effects of a single chain proteinase dimer and restores particle formation. J Virol 66: 567–572
Kräusslich HG, Fäcke M, Heuser AM, Konvalinka J, Zentgraf H (1995) The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol 69: 3407–3419
Kräusslich HG, Pawlita M, Hunter E, Zentgraf H (1996) The budding type of squirrel monkey retrovirus is influenced by the host cell (submitted for publication) Kuff EL, Lueders KK (1988) The intracisternal A particle gene family: structure and functional aspects. Adv Cancer Res 51: 183–276
Lawrence JB, Singer RH, Marselle LM (1989) Highly localized tracks of specific transcripts within interphase nuclei visualized by in situ hybridization. Cell 57: 493–502
Lawrence JB, Marselle LM, Byron KS, Johnson CV, Sullivan JL, Singer RH (1990) Subcellular localization of low-abundance human immunodeficiency virus nucleic acid sequences visualized by fluorescence in situ hybridization. Proc Natl Acad Sei USA 87: 5420–5424
Lee PP, Linial ML (1994) Efficient particle formation can occur if the matrix domain of human immunodeficiency virus type 1 Gag is substituted by a myristylation signal J Virol 68: 6644–6654
Leis J, Phillips N, Fu X, Tuazon PT, Traugh JA (1989) Phosphorylation of avian retrovirus matrix protein by Ca2+/phospholipid dependent protein kinase. Eur J Biochem 179: 415–422
Löchelt M, Flügel RM (1996) The human foamy virus pol gene is expressed as a Pro-Pol polyprotein and not as a Gag-Pol fusion protein. J Virol 70: 1033–1040
Lodge R, Göttlinger H, Gabuzda D, Cohen EA, Lemay G (1994) The intracytoplasmic domain of gp41 mediates polarized budding of human immunodeficiency virus type 1 in MDCK cells J Virol 68: 4857–4861
Lu YL, Spearman P, Ratner L (1993) Human immunodeficiency virus type 1 viral protein R localization in infected cells and virions. J Virol 67: 6542–6550
Luban J, Bossolt KL, Franke EK, Kalpana GV, Goff SP (1993) Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B. Cell 73: 1067–1078
Luftig RB, Lupo LD (1994) Viral interactions with the host cell cytoskeleton: the role of retroviral proteases. Trends Microbiol 2: 178–182
Mak J, Jiang M, Wainberg MA, Hammarskjold ML, Rekosh D, Kleiman L (1994) Role of Pr160gag pol in mediating the selective incorporation of tRNA(Lys) into human immunodeficiency virus type 1 particles. J Virol 68: 2065–2072
Mammano F, Kondo E, Sodroski J, Bukovsky A, Göttlinger HG (1995) Rescue of human immunodeficiency virus type 1 matrix protein mutants by envelope glycoproteins with short cytoplasmic domains. J Virol 69: 3824–3830
Massiah MA, Starich MR, Paschall C, Summers MF, Christensen AM, Sundquist Wl (1994) Threedimensional structure of the human immunodeficiency virus type 1 matrix protein J Mol Biol 244: 198–223
Matthews S, Barlow P, Boyd J, Barton G, Russell R, Mills H, Cunningham M, Meyers N, Burns N, Clark N et al (1994) Structural similarity between the p17 matrix protein of HIV 1 and interferon gamma. Nature 370: 666–668
McLauglin S, Aderem A (1995) The myristoyl-electrostatic switch: a modulator of reversible proteinmembrane interactions. TIBS 20: 272–276
Mergener K, Fäcke M, Welker R, Brinkmann V, Gelderblom HR, Kräusslich HG (1992) Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology 186: 25–39
Morikawa Y, Kishi T, Zhang WH, Nermut M, Hockley DJ, Jones IM (1995) A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17 J Virol 69: 4519–4523
Nash MA, Meyer MK, Decker GL, Arlinghaus RB (1993) A subset of Pr65gag is nucleus associated in murine leukemia virus infected cells. J Virol 67: 1350–1356
Niedrig M, Gelderblom HR, Pauli G, Marz J, Bickhard H, Wolf H, Modrow S (1994) Inhibition of infectious human immunodeficiency virus type 1 particle formation by Gag protein derived peptides. J Gen Virol 75: 1469–1474
Nieva JL, Bron R, Corver J, Wilschut (1994) Membrane fusion of Semliki Forest virus requires sphingolipids in the target membrane. EMBO J 13: 2797–2804
Oka T, Ohtsuki Y, Sonobe H, Furihata M, Miyoshi (1990) Suppressive effects of interferons on the production and release of human T-lymphotropic virus-l ( HTLV-I ). Arch Virol 115: 63–73
Orenstein JM (1992) Immunodeficiency virus infection. Ultrastruct Pathol 16: 179–210
Orenstein JM, Meitzer MS, Phipps T, Gendelman HE (1988) Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony stimulating factor 1 treated human monocytes: an ultrastructural study. J Virol 62: 2578–2586
Owens RJ, Compans RW (1989) Expression of the human immunodeficiency virus envelope glycoprotein is restricted to basolateral surfaces of polarized epithelial cells. J Virol 63: 978–982
Owens RJ, Dubay JW, Hunter E, Compans RW (1991) Human immunodeficiency virus envelope protein determines the site of virus release in polarized epithelial cells. Proc Natl Acad Sei USA 88: 3987–3991
Pal R, Reitz MS Jr, Tschachler E, Gallo RC, Sarngadharan MG, Veronese FD (1990) Myristoylation of gag proteins of HIV 1 plays an important role in virus assembly. AIDS Res Hum Retroviruses 6: 721–730
Pal R, Mumbauer S, Hoke GM, Takatsuki A, Sarngadharan MG (1991) Brefeldin A inhibits the processing and secretion of envelope glycoproteins of human immunodeficiency virus type 1. AIDS Res Hum Retroviruses 7: 707–712
Park J, Morrow CD (1992) The nonmyristoylated Pr160gag~po1 polyprotein of human immunodeficiency virus type 1 interacts with Pr55gag and is incorporated into viruslike particles J Virol 66: 6304–6313
Pautrat G, Suzan M, Salaun D, Corbeau P, Allasia C, Morel G, Filippi P (1990) Human immunodeficiency virus type 1 infection of U937 cells promotes cell differentiation and a new pathway of viral assembly. Virology 179: 749–758
Pearce-Pratt R, Malamud D, Phillips DM (1994) Role of the cytoskeleton in cell-to-cell transmission of human immunodeficiency virus J Virol 68: 2898–2905
Peitzsch RM, McLaughlin S (1993) Binding of acylated peptides and fatty acids to phospholipid vesicles: elevance to myristoylated proteins. Biochemistry 32: 10436–10443
Peng C, Ho BK, Chang TW, Chang NT (1989) Role of human immunodeficiency virus type 1 specific protease in core protein maturation and viral infectivity. J Virol 63: 2550–2556
Pepinsky RB, Vogt VM (1979) Identification of retrovirus matrix proteins by lipid protein cross-linking. J Mol Biol 131: 819–837
Pepinsky RB, Vogt VM (1984) Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping. J Virol 52: 145–153
Pessin JE, Glaser M (1983) Budding of Rous sarcoma virus and vesicular stomatitis virus from localized lipid regions in the plasma membrane of chicken embryo fibroblasts. J Biol Chem 255: 9044–9050
Pfeffer LM, Wang E, Tamm I (1980) Interferon inhibits the redistribution of cell surface components. J Exp Med 152: 469–474
Pfeffer LM, Landsberger FR, Tamm I (1981) ß-lnterferon-induced time-dependent changes in the plasma membrane lipid bilayer of cultured cells. J Interferon Res 1: 613–620
Phillips DM, Bourinbaiar AS (1992) Mechanism of HIV spread from lymphocytes to epithelia. Virology 186: 261–273
Phillips DM, Tan X (1992) HIV-1 infection of the trophoblast cell line BeWo: a study of virus uptake. AIDS Res Hum Retroviruses 8: 1683–1691
Pitha PM, Bilello JA, Riggin CH (1981) Effect of interferon on retrovirus replication. Tex Rep Biol Med 41: 603–609
Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS (1989) Interferon alpha but not AZT suppresses HIV expression in chronically infected cell lines. Science 244: 575–577
Pumplin DW, Bloch RJ (1993) The membrane skeleton. Trends Cell Biol 3: 113–117
Rao Z, Belyaev AS, Fry E, Roy P, Jones IM, Stuart Dl (1995) Crystal structure of SIV matrix antigen and implications for virus assembly. Nature 238: 743–747
Reicin AS, Paik S, Berkowitz RD, Luban J, Lowy I, Goff SP (1995) Linker insertion mutations in the human immunodeficiency virus type 1 gag gene: effects on virion particle assembly, release, and infectivity. J Virol 69: 642–650
Rein A, McClure MR, Rice NR, Luftig RB, Schultz AM (1986) Myristylation site in Pr65gag is essential for virus particle formation by Moloney murine leukemia virus. Proc Natl Acad Sei USA 83: 7246–7250
Rhee SS, Hunter E (1987) Myristylation is required for intracellular transport but not for assembly of D type retrovirus capsids. J Virol 61: 1045–1053
Rhee SS, Hunter E (1990a) Structural role of the matrix protein of type D retroviruses in gag polyprotein stability and capsid assembly. J Virol 64: 4383–4389
Rhee SS, Hunter E (1990b) A single amino acid substitution within the matrix protein of a type D retrovirus converts its morphogenesis to that of a type C retrovirus. Cell 63: 77–86
Rhee SS, Hunter E (1991) Amino acid substitutions within the matrix protein of type D retroviruses affect assembly, transport and membrane association of a capsid. EM BO J 10: 535–546
Royer M, Cerutti M, Gay B, Hong SS, Devauchelle G, Boulanger P (1991) Functional domains of HIV 1 gag polyprotein expressed in baculovirus infected cells. Virology 184: 417–422
Royer M, Hong SS, Gay B, Cerutti M, Boulanger P (1992) Expression and extracellular release of human immunodeficiency virus type 1 Gag precursors by recombinant baculovirus infected cells. J Virol 66: 3230–3235
Sagara J, Tsukita S, Yonemura S, Tsukita S, Kawai A (1995) Cellular actin-binding ezrin-radixin-moesin ( ERM) family proteins are incorporated into the rabies virion and closely associated with envelope proteins in the cell. Virology 206: 485–494
Satake M, Luftig RB (1982) Microtubule-depolymerizing agents inhibit Moloney murine leukemia virus production J Gen Virol 58: 339–349
Schätzl H, Gelderblom HR, Nitschko H, von der Helm K (1991) Analysis of non-infectious HIV particles produced in presence of HIV proteinase inhibitor. Arch Virol 120: 71–81
Schliephake AW, Rethwilm A (1994) Nuclear localization of foamy virus Gag precursor protein. J Virol 68: 4946–4954
Schubert U, Bour S, Ferrer-Montiel A, Montal M, Maldarelli F, Strebel K (1996a) The two biological activities of the human immunodeficiency virus type-1 Vpu protein involve two separate structural domains J Virol 70: 809–819
Schubert U, Henklein P, Ferrer-Montiel AV, Oblatt-Montal M, Strebel K, Montal M (1996b) Identification of an ion channel activity of the Vpu transmembrane domain and its function in the regulation of virus release from HIV-1 infected cells (submitted for publication) Schultz AM, Henderson LE, Oroszlan S (1988) Fatty acylation of proteins. Annu Rev Cell Biol 4: 611–647
Schultz AM, Rein A (1989) Unmyristylated Moloney murine leukemia virus Pr65gag is excluded from virus assembly and maturation events. J Virol 63: 2370–2373
Sen GC, Pinter A (1983) Interferon-mediated inhibition of production of Gazdar murine sarcoma virus, a retrovirus lacking env proteins and containing an uncleaved gag precursor. Virology 126: 403–407
Shoeman RL, Höner B, Stoller TJ, Kesselmeier C, Miedel MC, Traub P, Graves MC (1990) Human immunodeficiency virus type 1 protease cleaves the intermediate filament proteins vimentin, desmin, and glial fibrillary acidic protein. Proc Natl Acad Sei USA 87: 6336–6340
Shoeman RL, Kesselmeier C, Mothes E, Höner B, Traub P (1991) Non viral cellular substrates for human immunodeficiency virus type 1 protease. FEBS Lett 278: 199–203
Simons K, van Meer G (1988) Lipid sorting in epithelial cells. Biochemistry 27: 6197–6202
Smith AJ, Srinivasakumar N, Hammarskjold ML, Rekosh D (1993) Requirements for incorporation of Pr160gag pol from human immunodeficiency virus type 1 into virus like particles. J Virol 67: 2266–2275
Smith MS, Thresher RJ, Pagano JS (1991) Inhibition of human immunodeficiency virus type 1 morphogenesis in T cells by alpha interferon. Antimicrob Agents Chemother. 35: 62–67
Spearman P, Wang JJ, Vander Heyden N, Ratner L (1994) Identification of human immunodeficiency virus type 1 Gag protein domains essential to membrane binding and particle assembly. J Virol 68: 3232–3242
Srinivasakumar N, Hammarskjold ML, Rekosh D (1995) Characterization of deletion mutations in the capsid region of human immunodeficiency virus type 1 that affect particle formation and Gag-Pol precursor incorporation. J Virol 69: 6106–6114
Taniguchi H, Manenti S (1993) Interaction of myristoylated alanina-rich protein kinase C substrate ( MARCKS) with membrane phospholipids. J Biol Chem 268: 9960–9963
Terwilliger EF, Cohen EA, Lu YC, Sodroski JG, Haseltine WA (1989) Functional role of human immunodeficiency virus type 1 vpu. Proc Natl Acad Sei USA 86: 5163–5167
Thali M, Bukovsky A, Kondo E, Rosenwirth B, Walsh C, Sodroski J, Göttlinger HG (1994) Functional association of cyclophilin A with HIV-1 virions. Nature 372: 363–365
Thelen M, Rosen A, Nairn AC, Aderem A (1991) Regulation by phosphorylation of reversible association of myristoylated protein kinase C substrate with the plasma membrane. Nature 351: 320–322
Ulmer JB, Palade GE (1991) Effects of Brefeldin A on the Golgi complex, endoplasmic reticulum and viral envelope glycoproteins in murine erythroleukemia cells. Eur J Cell Biol 54: 38–54
Vieillard V, Lauret E, Rousseau V, de Maeyer E (1994) Blocking of retroviral infection at a step prior to reverse transcription in cells transformed to constitutively express interferon beta. Proc Natl Acad Sci USA 91: 2689–2693
Vlasuk GP, Waxman L, Davis LJ, Dixon RA, Schultz LD, Hofmann KJ, Tung JS, Schulman CA, Ellis RW, Bencen GH, et al (1989) Purification and characterization of human immunodeficiency virus (HIV) core precursor (p55) expressed in Saccharomyces cerevisiae. J Biol Chem 264: 12106–12112
von Schwedler U, Kornbluth RS, Trono D (1994) The nuclear localization signal of the matrix protein of human immunodeficiency virus type 1 allows the establishment of infection in macrophages and quiescent T lymphocytes. Proc Natl Acad Sci USA 91: 6992–6996
Wagner R, Demi L, Fliessbach H, Wanner G, Wolf H (1994) Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles. Virology 200: 162–175
Wang CT, Barklis E (1993) Assembly, processing, and infectivity of human immunodeficiency virus type 1 gag mutants. J Virol 67: 4264–4273
Wang CT, Zhang Y, McDermott J, Barklis E (1993) Conditional infectivity of human immunodeficiency virus matrix domain deletion mutant. J Virol 67: 7067–7076
Wang CT, Stegeman Olsen J, Zhang Y, Barklis E (1994) Assembly of HIV GAG p galactosidase fusion proteins into virus particles. Virology 200: 524–534
Wang E, Wolf BA, Lamb RA, Choppin PW, Goldberg AR (1976) The presence of actin in enveloped viruses. In: Goldman R, Pollard T, Rosenbaums J (eds) Cell motility. Cold Spring Harbor Laboratory, Cold Spring Harbor, pp 589–599
Wang E, Pfeffer LM, Tamm I (1981) Interferon increases the abundance of submembraneous microfilaments in HeLa-S3 cells in suspension culture. Proc. Natl. Acad. Sc. USA 78: 6281–6285
Weaver TA, Panganiban AT (1990) N myristoylation of the spleen necrosis virus matrix protein is required for correct association of the Gag polyprotein with intracellular membranes and for particle formation. J Virol 64: 3995–4001
Weldon RA Jr, Erdie CR, Oliver MG, Wills JW (1990) Incorporation of chimeric gag protein into retroviral particles. J Virol 64: 4169–4179
Welker R, Janetzko A, Krausslich HG (1996) Plasma membrane targeting of intracisternal A type particle polyproteins leads to particle release and specifically activates the viral proteinase (submitted for publication )
Wen W, Meinkoth JL, Tsien RY, Taylor SS (1995) Identification of a signal for rapid export of proteins from the nucleus. Cell 82: 463–473
Wills JW, Craven RC (1991) Form, function, and use of retroviral Gag proteins. AIDS 5: 639–654
Wills JW, Craven RC, Achacoso JA (1989) Creation and expression of myristylated forms of Rous sarcoma virus gag protein in mammalian cells. J Virol 63: 4331–4343
Wills JW, Craven RC, Weldon RA Jr, Nelle TD, Erdie CR (1991) Suppression of retroviral MA deletions by the amino terminal membrane binding domain of p60src. J Virol 65: 3804–3812
Yu G, Shen FS, Sturch S, Aquino A, Glazer Rl, Felsted RL (1995) Regulation of HIV-1 gag protein subcellular targeting by protein kinase C. J Biol Chem 270: 4792–4796
Yu SF, Baldwin DN, Gwynn SR, Yandapalli S, Linial M (1996) Human foamy virus replication: a pathway distinct from that of retroviruses and hepadnaviruses. Science 271: 1579–1582
Yu X, Yu QC, Lee TH, Essex M (1992a) The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle. J Virol 66: 5667–5670
Yu X, Yuan X, Matsuda Z, Lee TH, Essex M (1992b) The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions. J Virol 66: 4966–4971
Yuan X, Yu X, Lee TH, Essex M (1993) Mutations in the N terminal region of human immunodeficiency virus type 1 matrix protein block intracellular transport of the Gag precursor. J Virol 67: 6387–6394
Zhou W, Parent LJ, Wills JW, Resh MD (1994) Identification of a membrane binding domain within the amino terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol 68: 2556–2569
Zolotukhin AS, Valentin A, Pavlakis GN, Felber BK (1994) Continuous propagation of RRE(-) and Rev(-) RRE(-) human immunodeficiency type 1 molecular clones containing a cis-acting element of simian retrovirus type 1 in human peripheral blood lymphocytes. J Virol 68: 7944–7952
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Kräusslich, HG., Welker, R. (1996). Intracellular Transport of Retroviral Capsid Components. In: Kräusslich, HG. (eds) Morphogenesis and Maturation of Retroviruses. Current Topics in Microbiology and Immunology, vol 214. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-80145-7_2
Download citation
DOI: https://doi.org/10.1007/978-3-642-80145-7_2
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-80147-1
Online ISBN: 978-3-642-80145-7
eBook Packages: Springer Book Archive